CUSIP: 698340106
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,546,366
-
Share change
-
+10,546,366
-
Total reported value
-
$120,862,000
-
Price per share
-
$11.46
-
Number of holders
-
51
-
Value change
-
+$120,862,000
-
Number of buys
-
51
Quarterly Holders Quick Answers
What is CUSIP 698340106?
CUSIP 698340106 identifies PAND - PANDION THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of PANDION THERAPEUTICS INC - COM (PAND) as of Q3 2020
As of 30 Sep 2020,
PANDION THERAPEUTICS INC - COM (PAND) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,546,366 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Redmile Group, LLC, FEDERATED HERMES, INC., Logos Global Management LP, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, and Ikarian Capital, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.